Search results
FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'
Benzinga via Yahoo Finance· 5 days agoOn Wednesday, Boston Scientific Corporation (NYSE:BSX) said it recalled Obsidio Embolic by issuing a...
Cetera Trust Company N.A Makes New Investment in Boston Scientific Co. (NYSE:BSX)
ETF DAILY NEWS· 10 hours agoCetera Trust Company N.A bought a new position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional ...
Boston Sci issues corrective recall for Obsidio Embolic over safety concerns
Seeking Alpha· 6 days agoBoston Scientific (BSX) has issued a corrective recall for its embolization agent Obsidio, warning...
Lindbrook Capital LLC Raises Holdings in Boston Scientific Co. (NYSE:BSX)
ETF DAILY NEWS· 1 day agoLindbrook Capital LLC lifted its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 52.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and ...
Sumitomo Mitsui DS Asset Management Company Ltd Acquires 6,788 Shares of Boston Scientific Co....
ETF DAILY NEWS· 1 day agoSumitomo Mitsui DS Asset Management Company Ltd raised its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 4.5% in the 4th quarter, Holdings Channel.com reports. The ...
Boston Scientific (BSX) – Analysts’ Weekly Ratings Changes
ETF DAILY NEWS· 5 days ago4/15/2024 – Boston Scientific had its price target raised by analysts at Royal Bank of Canada from $70.00 to $78.00. 4/4/2024 – Boston Scientific had its price target raised by analysts at Evercore ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 1 day agoNEWARK, Del, April 22, 2024 (GLOBE NEWSWIRE) -- The peripheral vascular stent market value is expected to rise from US$ 4,267.70 million in 2024 to US$ 8,878.00 million by 2034. This market is analyzed to surge ahead at a CAGR of 7.60% over
Here's Why You Should Retain Medtronic (MDT) Stock for Now
Zacks via Yahoo Finance· 5 days agoThe segments that generate a majority of revenues for Medtronic are Spinal, Cardio Vascular, and...
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta,...
Investing.com· 2 days agoCan Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta,...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 12 hours agoElectroceuticals/Bioelectric Medicine Market to Reach $40.5 Billion, Globally, by 2032 at 7.4% CAGR: Allied Market Research PR Newswire PORTLAND, Ore., April 23, 2024 Increasing prevalence of chronic diseases, advancements in technology, and rising